Biovet, part of Bharat Biotech, has received approval from the CDSCO for its innovative lumpy skin disease vaccine, ...

Biovet, part of Bharat Biotech, received CDSCO approval for BIOLUMPIVAXIN, a novel LSD vaccine for dairy cattle and buffaloes ...

Biovet receives CDSCO license for LSD vaccine, a game-changer for animal health, developed in collaboration with ICAR.

Bharat Biotech's group company, Biovet, has launched the world's first-ever Lumpy Skin Disease (LSD) vaccine, Biolumpivaxin, ...

Biovet has secured a license from CDSCO for Biolumpivaxin, the world's only marker vaccine for Lumpy Skin Disease in cattle ...

In the last two years, around 200,000 cattle have died, millions lost their milk production capabilities due to LSD ...

Biolumpivaxin is a single vaccination regimen given once a year to cattle and buffaloes above 3 months of age.

The firm has claimed that it is the first such vaccine in the world for the highly infectious viral disease that affects ...

Bharat Biotech’s Biovet secures regulatory nod for Biolumpivaxin, developed with ICAR, to protect cattle and buffaloes from ...

Bharat Biotech in collaboration with the Indian Council for Agricultural Research(ICAR) has developed the world’s first vaccine for cattle’s Lumpy Skin Disease ...

Biovet, a subsidiary of Bharat Biotech, has received approval from CDSCO for its lumpy skin disease vaccine, Biolumpvaxin, ...

Biolumpivaxin will help in disease surveillance as it means the experts will be able to distinguish between vaccinated and naturally infected dairy cattle ...